267 related articles for article (PubMed ID: 26694922)
1. The Epidemiology of Male Breast Cancer.
Ferzoco RM; Ruddy KJ
Curr Oncol Rep; 2016 Jan; 18(1):1. PubMed ID: 26694922
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of male breast cancer.
Weiss JR; Moysich KB; Swede H
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):20-6. PubMed ID: 15668471
[TBL] [Abstract][Full Text] [Related]
3. [Male breast cancer: history, epidemiology, genetic and histopathology].
Leinung S; Horn LC; Backe J
Zentralbl Chir; 2007 Oct; 132(5):379-85. PubMed ID: 17907078
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
5. Male Breast Cancer: Epidemiology and Risk Factors.
Abdelwahab Yousef AJ
Semin Oncol; 2017 Aug; 44(4):267-272. PubMed ID: 29526255
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer.
Singer CF; Rappaport-Fuerhauser C; Sopik V; Narod SA
Clin Genet; 2015 Aug; 88(2):187-9. PubMed ID: 25112434
[TBL] [Abstract][Full Text] [Related]
8. [Male breast cancer].
Shin E
Nihon Rinsho; 2000 Apr; 58 Suppl():571-4. PubMed ID: 11026052
[No Abstract] [Full Text] [Related]
9. BRCA1/2 mutation analysis in male breast cancer families from North West England.
Evans DG; Bulman M; Young K; Howard E; Bayliss S; Wallace A; Lalloo F
Fam Cancer; 2008; 7(2):113-7. PubMed ID: 17636422
[TBL] [Abstract][Full Text] [Related]
10. Response to "Male Patients With Breast Cancer: Addressing Needs Using an Educational Task Force".
Mahon SM; Nagtalon Cutrone J; Baron RH
Clin J Oncol Nurs; 2018 Dec; 22(6):610. PubMed ID: 30452015
[TBL] [Abstract][Full Text] [Related]
11. CHEK2 1100delC is not a risk factor for male breast cancer population.
Syrjäkoski K; Kuukasjärvi T; Auvinen A; Kallioniemi OP
Int J Cancer; 2004 Jan; 108(3):475-6. PubMed ID: 14648717
[TBL] [Abstract][Full Text] [Related]
12. PALB2 analysis in BRCA2-like families.
Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
[TBL] [Abstract][Full Text] [Related]
13. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
Haraldsson K; Loman N; Zhang QX; Johannsson O; Olsson H; Borg A
Cancer Res; 1998 Apr; 58(7):1367-71. PubMed ID: 9537231
[TBL] [Abstract][Full Text] [Related]
14. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
[TBL] [Abstract][Full Text] [Related]
15. CHEK2*1100delC and male breast cancer risk in Israel.
Ohayon T; Gal I; Baruch RG; Szabo C; Friedman E
Int J Cancer; 2004 Jan; 108(3):479-80. PubMed ID: 14648719
[No Abstract] [Full Text] [Related]
16. CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status.
Gudmundsdottir K; Thorlacius S; Jonasson JG; Sigfusson BF; Tryggvadottir L; Eyfjord JE
Br J Cancer; 2003 Mar; 88(6):933-6. PubMed ID: 12644832
[TBL] [Abstract][Full Text] [Related]
17. BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
Mitri ZI; Jackson M; Garby C; Song J; Giordano SH; Hortobágyi GN; Singletary CN; Hashmi SS; Arun BK; Litton JK
Oncologist; 2015 Jun; 20(6):593-7. PubMed ID: 25948675
[TBL] [Abstract][Full Text] [Related]
18. The genetic epidemiology of male breast carcinoma.
Lynch HT; Watson P; Narod SA
Cancer; 1999 Sep; 86(5):744-6. PubMed ID: 10463967
[No Abstract] [Full Text] [Related]
19. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
[TBL] [Abstract][Full Text] [Related]
20. Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.
Coppa A; Buffone A; Capalbo C; Nicolussi A; D'Inzeo S; Belardinilli F; Colicchia V; Petroni M; Granato T; Midulla C; Zani M; Ferraro S; Screpanti I; Gulino A; Giannini G
Breast Cancer Res Treat; 2014 Dec; 148(3):629-35. PubMed ID: 25395318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
